Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment Statement on ILSI/HESI Research Programme on Alternative Cancer Models

Sign In to gain access to subscriptions and/or personal tools.

This Article

	Free Full Text (Free PDF) Free
	Alert me when this article is cited
	Alert me if a correction is posted
	Citation Map

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to Saved Citations
	Download to citation manager
	Request Permissions
	Request Reprints
	Add to My Marked Citations

Citing Articles

	Citing Articles via Google Scholar
	Citing Articles via Scopus

Google Scholar

	Search for Related Content

PubMed

	PubMed Citation


Social Bookmarking

	What's this?

References

ICH (2000). International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for human use (ICH). Harmonised Tripartite guideline, Testing for carcinogenicity of pharmaceuticals, 1997. Geneva, Switzerland.

Blain PG, Battershill JM, Venitt S., Cooper CC, Fielder RJ (1998). Consideration of short-term carcinogenicity tests using transgenic mouse models. In: Current Issues in Mutagenesis and Carcinogenesis, No. 87, Mutation Research, 403: 259—263.[Web of Science][Medline] [Order article via Infotrieve]

Robinson DE, MacDonald J. (2001). Background and Framework for ILSI's collaborative evaluation program on alternative models for carcinogenicity assessment. Toxicol Pathol 29(Suppl): 13—19.[Abstract/Free Full Text]

Popp JA (2001). Criteria for the evaluation of studies in transgenic models. Toxicol Pathol 29(Suppl): 20—23.[Abstract/Free Full Text]

French JE, Stoner R., Donehower LA (2001). The Nature of the heterzygous Trp53 Knockoutmodelforthe identificationmutagenic carcinogens. Toxicol Pathol 29(Suppl): 24—29.[Abstract/Free Full Text]

Storer RD, et al (2001). p53+/– Hemizygous knockout mouse: Overview of available data. Toxicol Pathol 29(Suppl): 30—50.[Abstract/Free Full Text]

Tennant RW, Stasiewicz S., Easton WC, Mennear JH, Spalding JW (2001). The Tg.AC (v-Ha-ras) transgenic mouse: Nature of the model. Toxicol Pathol 29(Suppl): 51—59.[Abstract/Free Full Text]

Eastin WC, et al (2001). Tg.AC genetically altered mouse: Assay working group overview of available data. Toxicol Pathol 29(Suppl): 60— 80.

Van Steeg H., de Vries A., van Oostron CThM, Van Benthem, Beems RB, van Kreijl CF (2001). DNA Repair Deficient Xpa and Xpa/p53+/– Knockout Mice: Nature of the models. Toxicol Pathol 29(Suppl): 109— 117.[Abstract/Free Full Text]

Coen F., et al (2001). Xpa and Xpa/p53+/– Knockout Mice: Overview of Available Data. Toxicol Pathol 29(Suppl): 117—127.[Abstract/Free Full Text]

Tamaoki N. (2001). The rasH2 Transgenic mouse. Nature of model and mechanistic study of tumourigenesis. Toxicol Pathol 29(Suppl): 81—89.[Abstract/Free Full Text]

Usui T., et al (2001). CB6F1-rasH2 mouse: Overview of available data. Toxicol Pathol 29(Suppl): 90—108.[Abstract/Free Full Text]

Department of Health (1998 ). 1998 Annual Report of the Committees on Toxicity,MutagenicityandCarcinogenicityofChemicalsinFood, Consumer Products and the Environment. Published Department of Health, London, England, 21145 1P 1-5K Mar 00 (OAK).

Van Tungeln LS, Beland FA, Casciano DA, Kadlubar FK, Fu PP (2001). Neonatal mouse model for short term carcinogenesis testing. Toxicol Pathol 29(Suppl): 198—199.[Free Full Text]

McClain R., et al (2001). Neonatal mouse model: Review of methods and results. Toxicol Pathol 29(Suppl): 128—137.[Abstract/Free Full Text]

Maulth RJ, Gibson DP, Bunch RJ, Caster L. (2001). The Syrian hamster embryo (SHE) cell transformation assay. Review of the methods and results from ILSI/HESI program on Alternative Cancer Testing. Toxicol Pathol 29(Suppl): 138—146.[Abstract/Free Full Text]